Home Therapy
Home Therapy

Lower airways

Title Section Menu position
bronchitis Therapy Lower airways
bronchitis- exacerbatie COPD Therapy Lower airways
comm-acq pneumonie - anaeroben Therapy Lower airways
comm-acq pneumonie - Klebsiella pneumoniae Therapy Lower airways
COVID-19 Therapy Lower airways
LWI 1.1 Community acquired pneumonie (CAP) - onbekende verwekker - mild (AMBU 0-1) Therapy Lower airways
LWI 1.2 Community acquired pneumonie (CAP) - onbekende verwekker - matig ernstig (AMBU-65 2) Therapy Lower airways
LWI 1.3 Community acquired pneumonie (CAP) - onbekende verwekker - ernstig (AMBU-65 3-5) GEEN IC-opname Therapy Lower airways
LWI 1.4 Community acquired pneumonie (CAP) - onbekende verwekker - ernstig (AMBU-65 3-5) MET IC-opname Therapy Lower airways
LWI 2.1 Hospital acquired pneumonie (HAP) Therapy Lower airways
LWI 3.1 Pneumonie - (bacterieel) Streptococcus pneumoniae (pneumokok) Therapy Lower airways
LWI 3.2 Pneumonie - (bacterieel) Haemophilus influenzae Therapy Lower airways
LWI 3.3 Pneumonie - (bacterieel) Atypische verwekkers (Legionella pneumophila, Chlamydophila pneumoniae/ psittaci, Mycoplasma pneumoniae, Q koorts/ Coxiella burnetti) Therapy Lower airways
LWI 3.4 Pneumonie - (bacterieel) Staphylococcus aureus (non-MRSA) Therapy Lower airways
LWI 3.5 Pneumonie - (bacterieel) Pseudomonas aeruginosa Therapy Lower airways
LWI 3.6 Pneumonie - (bacterieel) Bordetella pertussis (kinkhoest) Therapy Lower airways
LWI 5.1 Pneumonie - (fungaal) Pneumocystis jirovecii (PJP) Therapy Lower airways
LWI 5.2 Pneumonie - (fungaal) Aspergillus Therapy Lower airways
LWI 7.1 Cystic fibrosis (CF) Therapy Lower airways
LWI 8.1 Pleuraempyeem Therapy Lower airways
LWI 8.2 Longabces Therapy Lower airways